KoreaTimes(119) - Health & Science, National, page 28

Entertainment
& Arts

Sports

World

SCMP
Asia

Video

Photos

Site Map E-paper Subscribe Register LogIn
Site Map E-paper Subscribe Register LogIn

National

Health & Science

Thu, June 30, 2022 | 13:34

Teachers, parents disagree over gov't leaving quarantine management up to schools

Teachers and parents are showing mixed responses to the education ministry's new guidelines. The new guidelines leave the decision of whether to hold in-person or online classes for the spring semester up to the school.

Bahk Eun-ji | 2022-02-09 16:03

Korea's daily COVID-19 cases hit all-time high of nearly 50,000

Daily COVID-19 infections rose sharply to hit another high of nearly 50,000, Tuesday, amid the fast spread of the highly transmissible Omicron variant nationwide.

2022-02-09 10:12

When will COVID-19 become endemic in Korea?

The Omicron variant has driven up the number of COVID-19 infections to an unprecedented level around the world, while some countries have lifted antivirus measures and opted to treat the coronavirus like an endemic disease like the seasonal flu. The United Kingdom and Denmark have drastically eased COVID-19 restrictions, including face mask mandates, while Austria and the Net...

Lee Hyo-jin | 2022-02-08 16:24

Korea's daily COVID-19 cases hit all-time high of nearly 50,000

Korea's new COVID-19 cases above 35,000 for 4th day on Omicron surge

New daily COVID-19 infections stayed over 35,000 for the fourth day in a row Monday as the highly infectious Omicron variant of the coronavirus has become the country's dominant strain.

2022-02-08 09:55

When will COVID-19 become endemic in Korea?

President Moon warns against panic over surge of Omicron variant

President Moon Jae-in urged Koreans to refrain from “excessive fear” over the rapid spread of the Omicron variant and unveiled a new control scheme focused on self-monitoring and self-treatment by infected individuals to free up medical workers to treat severely ill patients. “After the Omicron variant became the dominant strain in Korea, the number of daily confirmed cases h...

Nam Hyun-woo | 2022-02-07 16:28

Celltrion's inhaled COVID-19 treatment found to be safe in clinical trial

Korean pharmaceutical giant Celltrion said Monday that its inhaled version of an antibody treatment candidate for COVID-19 has shown to be safe in a clinical trial.

2022-02-07 14:29

Korea's new COVID-19 cases above 35,000 for 3rd day as spread of Omicron picks up

New COVID-19 infections remained at more than 35,000 for the third day in a row Sunday, as the highly infectious Omicron variant rages across the country following a major holiday.

2022-02-07 10:14

COVID-19 cases surpass 1 million; Omicron infects 38,000 in 1 day

The COVID-19 Omicron variant is sweeping the nation, with an additional 38,691 infections reported on Saturday. The figure brought up the overall number of those in Korea who have been infected with the virus to over 1 million.

Ko Dong-hwan | 2022-02-06 16:13

Korea's daily COVID-19 cases hit fresh high of nearly 40,000

Daily COVID-19 infections shot to another record high Saturday, exceeding 38,000 as the highly transmissible Omicron variant of the coronavirus rages across the country following the Lunar New Year holiday.

2022-02-06 09:58

Korea's daily COVID-19 cases keep reaching new highs

Daily COVID-19 infections exceeded 30,000 for the first time, Friday, hitting another all-time high of over 36,000 due to the rapid spread of the Omicron variant of the coronavirus after the Lunar New Year holiday. The Korea Disease Control and Prevention Agency (KDCA) reported 36,362 new cases, including 36,162 local ones, raising the total to 971,018.

2022-02-05 10:08

Soaring use of self-test kit sparks concerns over underreporting of COVID-19 cases

21 22 23 24 25 26 27 28 29 30

CEO & Publisher : Oh Young-jin
Digital News Email : webmaster@koreatimes.co.kr
Tel : 02-724-2114
Online newspaper registration No : 서울,아52844
Date of registration : 2020.02.05
Masthead : The Korea Times
Copyright © koreatimes.co.kr. All rights reserved.